Cui L et al (2024) Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduct Target Ther 9(1):30. https://doi.org/10.1038/s41392-024-01738-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Trivedi MH (2020) Major depressive disorder in primary care: strategies for identification. J Clin Psychiatry. https://doi.org/10.4088/jcp.Ut17042br1c

Article  PubMed  Google Scholar 

Zhdanava M et al (2021) The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States. J Clin Psychiatry. https://doi.org/10.4088/JCP.20m13699

Article  PubMed  Google Scholar 

Jha MK, Mathew SJ (2023) Pharmacotherapies for Treatment-Resistant depression: how antipsychotics fit in the rapidly evolving therapeutic landscape. Am J Psychiatry 180(3):190–199. https://doi.org/10.1176/appi.ajp.20230025

Article  PubMed  Google Scholar 

Metaxa AM, Clarke M (2024) Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis. BMJ 385:e078084. https://doi.org/10.1136/bmj-2023-078084

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rossom RC et al (2016) Antidepressant adherence across diverse populations and healthcare settings. Depress Anxiety 33(8):765–774. https://doi.org/10.1002/da.22532

Article  CAS  PubMed  PubMed Central  Google Scholar 

Borbély É et al (2022) Novel drug developmental strategies for treatment-resistant depression. Br J Pharmacol 179(6):1146–1186. https://doi.org/10.1111/bph.15753

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carhart-Harris RL et al (2018) Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology 235(2):399–408. https://doi.org/10.1007/s00213-017-4771-x

Article  CAS  PubMed  Google Scholar 

Njenga C et al (2024) New and emerging treatments for major depressive disorder. BMJ 386:e073823. https://doi.org/10.1136/bmj-2022-073823

Article  CAS  PubMed  Google Scholar 

Grimm O et al (2018) Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination. Eur Neuropsychopharmacol 28(6):691–700. https://doi.org/10.1016/j.euroneuro.2018.03.016

Article  CAS  PubMed  Google Scholar 

Passie T et al (2002) The pharmacology of psilocybin. Addict Biol 7(4):357–364. https://doi.org/10.1080/1355621021000005937

Article  CAS  PubMed  Google Scholar 

Ling S et al (2022) Molecular mechanisms of psilocybin and implications for the treatment of depression. CNS Drugs 36(1):17–30. https://doi.org/10.1007/s40263-021-00877-y

Article  CAS  PubMed  Google Scholar 

Lowe H et al (2021) The therapeutic potential of psilocybin. Molecules. https://doi.org/10.3390/molecules26102948

Article  PubMed  PubMed Central  Google Scholar 

Sharma P et al (2023) Psilocybin history, action and reaction: a narrative clinical review. J Psychopharmacol 37(9):849–865. https://doi.org/10.1177/02698811231190858

Article  PubMed  Google Scholar 

Nichols DE (2020) Psilocybin: from ancient magic to modern medicine. J Antibiot (Tokyo) 73(10):679–686. https://doi.org/10.1038/s41429-020-0311-8

Article  CAS  PubMed  Google Scholar 

Wulff AB, Nichols CD, Thompson SM (2023) Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders. Neuropharmacology 231:109504. https://doi.org/10.1016/j.neuropharm.2023.109504

Article  CAS  PubMed  Google Scholar 

Johnson MW, Griffiths RR (2017) Potential therapeutic effects of psilocybin. Neurotherapeutics 14(3):734–740. https://doi.org/10.1007/s13311-017-0542-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raison CL et al (2023) Single-Dose psilocybin treatment for major depressive disorder: a randomized clinical trial. JAMA 330(9):843–853. https://doi.org/10.1001/jama.2023.14530

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goodwin GM et al (2022) Single-Dose psilocybin for a Treatment-Resistant episode of major depression. N Engl J Med 387(18):1637–1648. https://doi.org/10.1056/NEJMoa2206443

Article  CAS  PubMed  Google Scholar 

Davis AK et al (2021) Effects of Psilocybin-Assisted therapy on major depressive disorder: a randomized clinical trial. JAMA Psychiatry 78(5):481–489. https://doi.org/10.1001/jamapsychiatry.2020.3285

Article  PubMed  PubMed Central  Google Scholar 

Fang S, Yang X, Zhang W (2024) Efficacy and acceptability of psilocybin for primary or secondary depression: a systematic review and meta-analysis of randomized controlled trials. Front Psychiatry 15:1359088. https://doi.org/10.3389/fpsyt.2024.1359088

Article  PubMed  PubMed Central  Google Scholar 

Li NX et al (2022) Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis. J Affect Disord 296:26–34. https://doi.org/10.1016/j.jad.2021.09.041

Article  CAS  PubMed  Google Scholar 

Yu CL et al (2022) Trajectory of antidepressant effects after Single- or Two-Dose administration of psilocybin: a systematic review and multivariate meta-analysis. J Clin Med. https://doi.org/10.3390/jcm11040938

Article  PubMed  PubMed Central  Google Scholar 

Page MJ et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71

Article  PubMed  PubMed Central  Google Scholar 

Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389. https://doi.org/10.1192/bjp.134.4.382

Article  CAS  PubMed  Google Scholar 

Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23(1):56–62. https://doi.org/10.1136/jnnp.23.1.56

Article  CAS  PubMed  PubMed Central  Google Scholar 

McGuinness LA, Higgins JPT (2020) Risk-of-bias visualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. https://doi.org/10.1002/jrsm.1411. n/a(n/a)

Article  Google Scholar 

Higgins JPT, Thomas J, Chandler J, Cumpston M, Cumpston J, Li T, Page MJ, Welch VA (eds) (2023) Cochrane handbook for systematic reviews of interventions version 6.5 (updated August 2024). Cochrane

Sterne JAC et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https://doi.org/10.1136/bmj.l4898

Article  PubMed  Google Scholar 

Team RC (2023) R: A Language and environment for statistical computing. R Foundation for Statistical Computing

Field AP, Gillett R (2010) How to do a meta-analysis. Br J Math Stat Psychol 63(Pt 3):665–694. https://doi.org/10.1348/000711010x502733

Article  PubMed  Google Scholar